Thailand MedPark Hospital IVF Success Rate Assessment: An Analysis Based on Age and Clinical Indicators
Opening: Real Consultation Scenario
Last month, a 43-year-old client came to the studio. As soon as she sat down, she pushed her phone across the table. On the screen was an article with the headline "MedPark Hospital Thailand Success Rate 80%." She said, "I've looked at several hospitals, and this one has the highest number. Is it real?" I asked her if she had noticed the average age of the patients mentioned in that article. She shook her head. I encounter this scenario almost every week—many people interpret "success rate" as a fixed number, but in reality, it is directly related to your own age, ovarian function, and embryo condition. Discussing success rates without considering individual circumstances is meaningless.
What is the actual IVF success rate at MedPark Hospital?
The Reproductive Center at MedPark Hospital (formerly under the BDMS group) in Bangkok is one of the institutions with relatively high hardware configuration, especially its embryo laboratory equipment and quality control system, which have a good reputation in the industry. However, the "success rate" needs to be broken down:
- Patients under 35 – The live birth rate per single frozen embryo transfer is roughly in the 50%–60% range (estimated based on industry reports from the Thai Society for Reproductive Medicine and the hospital's clinical trends). This data is generally on par with Thailand's leading reproductive centers.
- Patients aged 35–40 – The live birth rate is approximately 30%–45%. The main reason for the decline is the increased rate of chromosomal aneuploidy in eggs with age.
- Patients aged 40–42 – The live birth rate is about 15%–25%. If PGT is used to screen for normal embryos, the live birth rate per single transfer can approach around 30%. However, the problem is that many people in this age group cannot develop blastocysts after egg retrieval or have no normal embryos to transfer.
- Patients over 43 – The live birth rate is generally below 10%. MedPark, like other reputable hospitals, will honestly inform patients of this situation and recommend considering egg donation options.
It should be noted that the above figures are comprehensive industry reference ranges, not precise statistics officially released by MedPark. Thai hospitals generally do not publicly disclose success rates broken down by age. Any promotional claim stating "MedPark's success rate is as high as XX%" requires caution regarding the source of the data.
What variables do reproductive specialists focus on more?
Having communicated with several doctors at MedPark, the three core indicators they value most when assessing patients are not the "hospital's average success rate":
- Ovarian Reserve – AMH, FSH, and Antral Follicle Count (AFC) determine how many eggs can be obtained through ovarian stimulation. If AMH is below 0.5 ng/mL, FSH is above 12 IU/L, and AFC is less than 4, regardless of which hospital you go to, the number of eggs retrieved is unlikely to exceed 3–5.
- Embryo Euploidy Rate – This is the key factor affecting implantation success. A chromosomally normal embryo has an implantation probability of about 50%–60% in a receptive endometrium; abnormal embryos will generally not implant or will result in early miscarriage. MedPark's PGT technology (NGS platform) is a mature application in Thailand, but whether an embryo is normal depends on the quality of the egg, which the hospital cannot change.
- Endometrial Receptivity – This includes endometrial thickness, morphology, blood flow, and the presence of chronic endometritis, polyps, or adhesions. MedPark routinely performs hysteroscopy or endometrial microbiome testing (EMMA/ALICE) before transfer, a more meticulous process than some clinics.
As one reproductive specialist put it: "What a hospital can do is optimize the laboratory conditions, tailor the stimulation protocol to the best fit, and time the transfer most accurately. But if the egg itself has a high rate of chromosomal abnormalities, no laboratory can magically create a normal embryo." This sentence is worth hearing repeatedly for anyone concerned about success rates.
Decision-making logic differs completely by age group
| Age Group | Typical Ovarian Status | MedPark's Advantages | Issues to Watch Out For |
|---|---|---|---|
| ≤34 years | AMH ≥ 2.5, AFC ≥ 10 | Good lab conditions, high blastocyst formation rate, PGT optional | Avoid overtreatment; not everyone needs PGT |
| 35–38 years | AMH 1.0–2.5, AFC 6–10 | Individualized stimulation protocols, PGT improves single transfer efficiency | May need to accumulate embryos; be mentally prepared for multiple cycles |
| 39–42 years | AMH 0.5–1.5, AFC 4–8 | PGT screens for normal embryos, avoiding ineffective transfers | Low egg yield, high risk of blastocyst culture failure, heavily dependent on lab |
| ≥43 years | AMH < 0.5, AFC < 4 | Egg donation program is legal and procedurally standardized | Extremely low success rate with own eggs; need realistic expectations |
MedPark has a relatively concentrated reputation among the intermediate age group of 35–42, because its laboratory conditions are more beneficial for embryos of "borderline quality"—for example, when only 3–5 blastocysts are available for biopsy, the stability of the lab and the embryologist's experience directly impact the final number of normal embryos obtained.
Objective differences between MedPark and other hospitals in Bangkok
Many people compare Jetanin, BNH, Bumrungrad, and MedPark when choosing a hospital. Here are some practical differences:
- MedPark's general hospital background – When issues like uterine fibroids, adenomyosis, or immune problems require multidisciplinary consultation, MedPark's advantage becomes apparent. It can directly refer patients to reproductive surgery, endocrinology, or rheumatology departments within the hospital, saving patients from having to visit other hospitals.
- Laboratory equipment – MedPark's embryo incubators use a time-lapse system, allowing continuous monitoring of embryo development and reducing disturbance from opening the incubator. This places it in the same tier as the high-end labs of Bumrungrad and Jetanin.
- Physician turnover – The reproductive medicine team at MedPark has seen some personnel changes in the past few years. Different doctors have different stimulation styles (e.g., medication dosage, trigger timing). If this is a concern, you can request to see a specific doctor consistently.
- Service process – MedPark has a high degree of internationalization, with relatively standardized translation and coordination services. However, the process is also quite standardized, unlike some smaller clinics that can be fully adjusted to personal preferences.
No hospital is "absolutely the best." The key is whether your situation matches the hospital's strengths. For example, for patients with normal ovarian function and younger age, there is no essential difference in success rates between MedPark and Jetanin. However, for cases of repeated implantation failure or complex situations requiring multidisciplinary collaboration, MedPark's general hospital advantage is more pronounced.
Three key details often overlooked but affecting success rates
① Embryo grading standards are not globally uniform
MedPark uses the Gardner grading system, but different embryologists may grade the same blastocyst differently. The implantation rate between a Grade A and Grade B blastocyst can differ by 10%–15%. It is recommended not just to look at "how many blastocysts" you have, but to ask for the specific grades and biopsy results.
② Frozen embryo transfer success rates are generally higher than fresh embryo transfer
This is because the endometrium after ovarian stimulation, influenced by estrogen, may deviate from the optimal receptive window. MedPark now uses a "freeze-all + elective transfer" approach for most protocols, allowing for better endometrial preparation and higher implantation rates. If you prefer a fresh embryo transfer, you need to confirm with your doctor that the endometrial conditions are suitable.
③ PGT eliminates many embryos, but the implantation rate per individual embryo increases
Many people think "doing PGT resulted in no embryos to transfer, so the hospital's technology must be bad." In fact, PGT's role is screening, not improvement. For patients over 35, the embryo euploidy rate is about 30%–50%. After PGT, more than half of the embryos may be eliminated. This is a biological law, not a problem with the hospital.
Common misconceptions and pitfalls
Myth 1: "MedPark has a high success rate, so I will succeed too."
This is the most dangerous idea. Success rate is a statistical concept; for an individual, it is only 0% or 100%. A 39-year-old patient with an AMH of 0.8 underwent two cycles at MedPark without forming a transferable embryo, while a 31-year-old patient she met there succeeded on her first attempt. The "MedPark experience" was completely different for these two women.
Myth 2: "The agent said they have internal channels to guarantee success."
MedPark officially does not have a "success guaranteed" program. Any third-party agency promising a success rate is essentially exploiting information asymmetry. Reputable hospitals will only provide an estimated range based on test results, not a guarantee.
Myth 3: "MedPark has a good lab, so even poor-quality eggs can develop into blastocysts."
Laboratory conditions can reduce losses during embryo culture, but they cannot change the chromosomal status of the egg itself. If the egg quality is poor (e.g., due to advanced age or premature ovarian insufficiency), no laboratory can turn an abnormal embryo into a normal one.
Analysis of two real scenarios
Scenario 1: 37 years old, AMH 1.1, FSH 9.8, AFC 5.
This patient had previously undergone 2 egg retrievals at another clinic, obtaining 3–4 eggs each time, with all blastocyst cultures failing. After switching to MedPark, the doctor adjusted the stimulation protocol (using an antagonist protocol with growth hormone pretreatment). In one cycle, she obtained 6 eggs, which developed into 3 blastocysts. After PGT, 1 was normal, and the transfer resulted in a successful pregnancy. In this case, MedPark's value lay in two aspects: the adjustment of the stimulation protocol and the lab's ability to culture borderline embryos. However, even so, only 1 out of 3 blastocysts was normal, indicating that age-related chromosomal abnormalities remained the primary limitation.
Scenario 2: 32 years old, undergoing IVF due to severe male factor infertility (oligoasthenoteratozoospermia), AMH 4.2, FSH 6.5, AFC 14.
In one cycle, she obtained 16 eggs, which developed into 9 blastocysts. PGT was not performed, and the first transfer was successful. The success in this case was more attributable to the patient's youth and good ovarian function. MedPark's lab simply played its normal supportive role. If she had gone to another hospital with equally good laboratory facilities, the outcome would likely have been the same.
These two scenarios illustrate that MedPark's advantage is more evident in "borderline situations"—when ovarian reserve is average and embryo quality is on the edge, a good lab and individualized protocols can make a difference. For younger patients with normal ovarian function, the difference in success rates between different reputable hospitals is minimal.
Practitioner's observation: MedPark's true positioning
In my years in the Thai assisted reproduction industry, my feeling is that MedPark is a hospital with a "high floor, but the ceiling depends on the individual." Its lab quality control, equipment investment, and international service processes are all top-tier, meaning it is unlikely to experience failures due to operational errors or unstable culture environments. For most patients, MedPark offers a stable and reliable treatment process.
However, its "ceiling" depends on the patient's own conditions. For young patients with good ovarian function, the success rate at MedPark is not significantly different from other leading hospitals. For patients with poor conditions, MedPark can only do its best—multidisciplinary collaboration, individualized protocols, and meticulous lab support—but it cannot overcome biological limitations.
Additionally, I have noticed a trend: MedPark has invested more in genetic counseling and clinical application of PGT in the past two years. For patients with clear genetic indications or recurrent miscarriage, its overall solution is relatively comprehensive. However, for young couples undergoing IVF purely due to tubal factors or male factors, the difference between MedPark and other hospitals is small. There is no need to blindly believe the claim that "MedPark's success rate is higher."
Risk Reminder
IVF is not a gamble you can "surely win," especially when age is advanced or ovarian reserve has significantly declined. MedPark's laboratory conditions and doctor experience can improve the efficiency of a single cycle to a certain extent, but they cannot reverse the decline in egg quality caused by age. Before making a decision, please ensure you complete the following tests:
- Female: AMH, FSH, LH, E2, Antral Follicle Count, Thyroid function, Karyotype
- Male: Semen analysis (including morphology and DNA fragmentation), Karyotype, Infectious disease screening
If test results suggest a success rate below 10%–15% (e.g., over 43 years old, AMH < 0.5, FSH > 15), it is advisable to have an honest discussion with your doctor about egg donation or embryo donation options to avoid the financial and emotional toll of repeated attempts. MedPark also offers these options with compliant procedures. Rational decision-making is more important than "trying one more time."
AMH FSH Antral Follicle Count Semen Analysis Chromosomal Testing PGT Frozen Embryo Transfer Embryo Culture Ovarian Stimulation Protocol Luteal Phase Support Hysteroscopy Endometrial Receptivity Thailand IVF Hospital Selection Advanced Maternal Age IVF Preparation Overseas IVF Documentation
